A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatmentnaive metastatic pancreatic cancer (GIANT): ECOG-ACRIN EA2186-Trials in progress
Publication
, Conference
Dotan, E; Catalano, PJ; Lenchik, L; Boutin, R; Yao, X; Beg, SS; Vijayvergia, N; Gatsonis, C; Zhen, DB; Li, D; Wagner, LI; Simon, MA; Wong, TZ ...
Published in: JOURNAL OF CLINICAL ONCOLOGY
2022
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2022
Volume
40
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Dotan, E., Catalano, P. J., Lenchik, L., Boutin, R., Yao, X., Beg, S. S., … O’Dwyer, P. J. (2022). A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatmentnaive metastatic pancreatic cancer (GIANT): ECOG-ACRIN EA2186-Trials in progress. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40).
Dotan, Efrat, Paul J. Catalano, Leon Lenchik, Robert Boutin, Xin Yao, Shaalan Shaalan Beg, Namrata Vijayvergia, et al. “A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatmentnaive metastatic pancreatic cancer (GIANT): ECOG-ACRIN EA2186-Trials in progress.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 40, 2022.
Dotan E, Catalano PJ, Lenchik L, Boutin R, Yao X, Beg SS, et al. A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatmentnaive metastatic pancreatic cancer (GIANT): ECOG-ACRIN EA2186-Trials in progress. In: JOURNAL OF CLINICAL ONCOLOGY. 2022.
Dotan, Efrat, et al. “A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatmentnaive metastatic pancreatic cancer (GIANT): ECOG-ACRIN EA2186-Trials in progress.” JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022.
Dotan E, Catalano PJ, Lenchik L, Boutin R, Yao X, Beg SS, Vijayvergia N, Gatsonis C, Zhen DB, Li D, Wagner LI, Simon MA, Wong TZ, O’Dwyer PJ. A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatmentnaive metastatic pancreatic cancer (GIANT): ECOG-ACRIN EA2186-Trials in progress. JOURNAL OF CLINICAL ONCOLOGY. 2022.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2022
Volume
40
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences